Platelet function testing to predict hyporesponsiveness to clopidogrel in patients with chest pain seen in the emergency department

References

• IakovouISchmidtTBonizzoniEIncidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stentsJAMA2005293172126213015870416
   PubMed Web of Science ®Google Scholar
• KushnerFGHandMSmithSCJr2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice GuidelinesJ Am Coll Cardiol200954232205224119942100
   PubMed Web of Science ®Google Scholar
• SerebruanyVLSteinhublSRBergerPBMalininAIBhattDLTopolEJVariability in platelet responsiveness to clopidogrel among 544 individualsJ Am Coll Cardiol200545224625115653023
   PubMed Web of Science ®Google Scholar
• BonelloLTantryUSMarcucciRConsensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphateJ Am Coll Cardiol2010561291993320828644
   PubMed Web of Science ®Google Scholar
• PriceMJColemanJLSteinhublSRWongGBCannonCPTeirsteinPSOnset and offset of platelet inhibition after high-dose clopidogrel loading and standard daily therapy measured by a point-of-care assay in healthy volunteersAm J Cardiol200698568168416923461
   PubMed Web of Science ®Google Scholar
• AngiolilloDJFernandez-OrtizABernardoEVariability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectivesJ Am Coll Cardiol200749141505151617418288
   PubMed Web of Science ®Google Scholar
• HolmesDRJrDehmerGJKaulSLeiferDO’GaraPTSteinCMACCF/AHA clopidogrel clinical alert: approaches to the FDA “boxed warning”: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the American Heart Association endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic SurgeonsJ Am Coll Cardiol201056432134120633831
   PubMed Web of Science ®Google Scholar
• GurbelPABlidenKPHiattBLO’ConnorCMClopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivityCirculation2003107232908291312796140
   PubMed Web of Science ®Google Scholar
• MatetzkySShenkmanBGuettaVClopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarctionCirculation2004109253171317515184279
   PubMed Web of Science ®Google Scholar
• AndersonJLAdamsCDAntmanEMACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency MedicineJ Am Coll Cardiol2007507e1e15717692738
   PubMed Web of Science ®Google Scholar
• CuissetTFrereCQuiliciJHigh post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndromeJ Thromb Haemost20064354254916371119
   PubMed Web of Science ®Google Scholar
• BonelloLPaganelliFArpin-BornetMVasodilator-stimulated phosphoprotein phosphorylation analysis prior to percutaneous coronary intervention for exclusion of postprocedural major adverse cardiovascular eventsJ Thromb Haemost2007581630163617488353
   PubMed Web of Science ®Google Scholar
• BuonamiciPMarcucciRMiglioriniAImpact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosisJ Am Coll Cardiol200749242312231717572245
   PubMed Web of Science ®Google Scholar
• PriceMJBedside evaluation of thienopyridine antiplatelet therapyCirculation2009119192625263219451364
   PubMed Web of Science ®Google Scholar
• PriceMJBergerPBAngiolilloDJEvaluation of individualized clopidogrel therapy after drug-eluting stent implantation in patients with high residual platelet reactivity: design and rationale of the GRAVITAS trialAm Heart J2009157581882419376306
   PubMed Web of Science ®Google Scholar
• PriceMJAngiolilloDJTeirsteinPSPlatelet reactivity and cardiovascular outcomes after percutaneous coronary intervention: a time-dependent analysis of the Gauging Responsiveness with a VerifyNow P2Y12 assay: Impact on Thrombosis and Safety (GRAVITAS) trialCirculation2011124101132113721875913
   PubMed Web of Science ®Google Scholar
• MalininAPokovASwaimLKotobMSerebruanyVValidation of a VerifyNow-P2Y12 cartridge for monitoring platelet inhibition with clopidogrelMethods Find Exp Clin Pharmacol200628531532216845449
   PubMedGoogle Scholar
• LordkipanidzeMPharandCNguyenTASchampaertEDiodatiJGAssessment of VerifyNow P2Y12 assay accuracy in evaluating clopidogrel-induced platelet inhibitionTher Drug Monit200830337237818520610
   PubMed Web of Science ®Google Scholar
• MehranRThe PARIS Registry; Patterns of Non-Adherence to Anti-Platelet Regimens In Stented Patients: An Observational Single Arm StudyProceedings of the 23rd Annual Transcatheter Cardiovascular Therapeutics Conference2011 Nov 7–11San Francisco, CA, USA
   Google Scholar
• GurbelPABlidenKPGuyerKPlatelet reactivity in patients and recurrent events post-stenting: results of the PREPARE post-stenting studyJ Am Coll Cardiol200546101820182616286165
   PubMed Web of Science ®Google Scholar
• MarcucciRGoriAMPanicciaRCardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-upCirculation2009119223724219118249
   PubMed Web of Science ®Google Scholar
• PriceMJEndemannSGollapudiRRPrognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantationEur Heart J2008298992100018263931
   PubMed Web of Science ®Google Scholar
• SharmaRKReddyHKSharmaRThe interaction between clopidogrel and proton pump inhibtors (PPI): is there any clinical relevanceClin Pharmacol2011215516222291500
   PubMedGoogle Scholar
• O’DonoghueMLBraunwaldEAntmanEMPharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trialsLancet2009374969498999719726078
   PubMed Web of Science ®Google Scholar
• LeetHPatonRCPassaPCaenJPFibrinogen binding and ADP-induced aggregation in platelets from diabetic subjectsThromb Res1981241–21431507330834
   PubMed Web of Science ®Google Scholar
• MandalSSarodeRDashSDashRJHyperaggregation of platelets detected by whole blood platelet aggregometry in newly diagnosed noninsulin-dependent diabetes mellitusAm J Clin Pathol199310021031078356939
   PubMed Web of Science ®Google Scholar
• AngiolilloDJBernardoERamirezCInsulin therapy is associated with platelet dysfunction in patients with type 2 diabetes mellitus on dual oral antiplatelet treatmentJ Am Coll Cardiol200648229830416843179
   PubMed Web of Science ®Google Scholar
• FerreiraIAMockingAIFeijgeMAPlatelet inhibition by insulin is absent in type 2 diabetes mellitusArterioscler Thromb Vasc Biol200626241742216339499
   PubMed Web of Science ®Google Scholar
• AngLPalakodetiVKhalidAElevated plasma fibrinogen and diabetes mellitus are associated with lower inhibition of platelet reactivity with clopidogrelJ Am Coll Cardiol200852131052105918848137
   PubMed Web of Science ®Google Scholar
• AngiolilloDJBernardoESabateMImpact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery diseaseJ Am Coll Cardiol200750161541154717936152
   PubMed Web of Science ®Google Scholar
• MangiacapraFPattiGPeaceAComparison of platelet reactivity and periprocedural outcomes in patients with versus without diabetes mellitus and treated with clopidogrel and percutaneous coronary interventionAm J Cardiol2010106561962320723634
   PubMed Web of Science ®Google Scholar
• MortensenSBLarsenSBGroveELKristensenSDHvasAMReduced platelet response to aspirin in patients with coronary artery disease and type 2 diabetes mellitusThromb Res20101264e318e32220451957
   PubMed Web of Science ®Google Scholar
• CollinsSDTorgusonRGagliaMAJrDoes black ethnicity influence the development of stent thrombosis in the drug-eluting stent era?Circulation2010122111085109020805432
   PubMed Web of Science ®Google Scholar
• MegaJLCloseSLWiviottSDCytochrome p-450 polymorphisms and response to clopidogrelN Engl J Med2009360435436219106084
   PubMed Web of Science ®Google Scholar
• BrandtJTCloseSLIturriaSJCommon polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrelJ Thromb Haemost20075122429243617900275
   PubMed Web of Science ®Google Scholar
• DestaZZhaoXShinJGFlockhartDAClinical significance of the cytochrome P450 2C19 genetic polymorphismClin Pharmacokinet2002411291395812222994
   PubMed Web of Science ®Google Scholar
• LuoHRPolandRELinKMWanYJGenetic polymorphism of cytochrome P450 2C19 in Mexican Americans: a cross-ethnic comparative studyClin Pharmacol Ther2006801334016815315
   PubMed Web of Science ®Google Scholar
• RobertsJReassessment of Anti-platelet therapy Using Individualized Strategy Based on Genetic Evaluation (RAPID GENE)Proceedings of the 23rd Annual Transcatheter Cardiovascular Therapeutics Conference2011 Nov 7–11San Francisco, CA, USA
   Google Scholar
• SharmaRKVoelkerDJSharmaRReddyHKDodHMarshJDEvolving role of platelet function testing in coronary artery interventionsVasc Health Risk Manag20128657522371653
   PubMedGoogle Scholar
• StoneGWAssessment of dual anti-platelet therapy with drug eluting stents (ADAPT-DES)Proceedings of the 23rd Annual Transcatheter Cardiovascular Therapeutics Conference2011 Nov 7–11San Francisco, CA, USA
   Google Scholar
• WiviottSDBraunwaldEMcCabeCHPrasugrel versus clopidogrel in patients with acute coronary syndromesN Engl J Med2007357202001201517982182
   PubMed Web of Science ®Google Scholar
• WallentinLBeckerRCBudajATicagrelor versus clopidogrel in patients with acute coronary syndromesN Engl J Med2009361111045105719717846
   PubMed Web of Science ®Google Scholar